Multicenter Automatic Defibrillator Implantation Trial-Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD): Design and clinical protocol.
暂无分享,去创建一个
Wojciech Zareba | Christopher Beck | Arthur J Moss | Mark Estes | Henry Greenberg | Jagmeet P. Singh | Jagmeet P Singh | Claudio Schuger | Valentina Kutyifa | S. Solomon | A. Moss | W. Zareba | D. Cannom | C. Schuger | I. Goldenberg | H. Klein | D. Wilber | M. Estes | R. Knops | C. Beck | H. Greenberg | Mary W. Brown | J. Poole | V. Kutyifa | J. Daubert | Stephen Hammes | David T. Huang | M. Kosiborod | Ilan Goldenberg | Jeanne Poole | Reinoud Knops | Helmut Klein | Mary W Brown | David Wilber | David Cannom | Scott Solomon | James Daubert | Stephen Hammes | David Huang | Mikhail Kosiborod
[1] Karl Swedberg,et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. , 2003, The New England journal of medicine.
[2] J. Kalbfleisch,et al. The Statistical Analysis of Failure Time Data , 1980 .
[3] Karl Swedberg,et al. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. , 2008, European heart journal.
[4] S. Solomon,et al. Association of QRS duration and outcomes after myocardial infarction: the VALIANT trial. , 2006, Heart rhythm.
[5] Fred S Apple,et al. Third universal definition of myocardial infarction , 2012 .
[6] M. Drazner,et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.
[7] A. Moss,et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.
[8] Helmut Baumgartner,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, European journal of heart failure.
[9] T. Vassiliades,et al. Bilateral internal thoracic artery grafting is associated with significantly improved long-term survival, even among diabetic patients. , 2012, The Annals of thoracic surgery.
[10] L. Jordaens,et al. The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort. , 2012, Journal of the American College of Cardiology.
[11] Juerg Schwitter,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.
[12] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.
[13] B. Turnbull,et al. Group Sequential Methods with Applications to Clinical Trials , 1999 .
[14] P. Erwin,et al. Bilateral internal thoracic artery harvest and deep sternal wound infection in diabetic patients. , 2013, The Annals of thoracic surgery.
[15] J. Oss,et al. PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .
[16] M. Drazner,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[17] K. Dickstein,et al. Aliskiren, ALTITUDE, and the implications for ATMOSPHERE , 2012, European journal of heart failure.
[18] A. Moss,et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. , 2008, Journal of the American College of Cardiology.
[19] Daniel R. Frisch,et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. , 2011, Journal of the American College of Cardiology.
[20] H. Huikuri,et al. Sudden cardiac death after myocardial infarction in patients with type 2 diabetes. , 2010, Heart rhythm.
[21] S. Yusuf,et al. Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction: Results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry , 2000, Circulation.
[22] H. Uno,et al. The inter‐relationship of diabetes and left ventricular systolic function on outcome after high‐risk myocardial infarction , 2010, European journal of heart failure.
[23] L E Hinkle,et al. Clinical Classification of Cardiac Deaths , 1982, Circulation.
[24] William J. Hall,et al. Sequential tests and estimators after overrunning based on maximum‐likelihood ordering , 2002 .
[25] H. Wellens,et al. Out-of-hospital cardiac arrest--the relevance of heart failure. The Maastricht Circulatory Arrest Registry. , 2003, European heart journal.
[26] F. Cosentino,et al. The 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. , 2019, European heart journal.
[27] D. Todd,et al. United Kingdom national experience of entirely subcutaneous implantable cardioverter-defibrillator technology: important lessons to learn. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[28] Karen L. Gunson,et al. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. , 2006, Journal of the American College of Cardiology.
[29] Alexander H Maass,et al. An entirely subcutaneous implantable cardioverter-defibrillator. , 2010, The New England journal of medicine.
[30] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[31] Sanjiv J. Shah,et al. Mode of Death in Heart Failure With Preserved Ejection Fraction. , 2017, Journal of the American College of Cardiology.
[32] Hung-Fat Tse,et al. Sudden Cardiac Death After Myocardial Infarction in Type 2 Diabetic Patients With No Residual Myocardial Ischemia , 2012, Diabetes Care.
[33] P. Lambiase,et al. Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry , 2014, European heart journal.